Weekly Recap: 13 Health Press Releases You Might Have Missed


(MENAFN- PR Newswire) A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the first nasal spray flu vaccine, upcoming disease awareness campaigns and more.

NEW YORK, Sept. 27, 2024 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.

The list below includes the headline (with a LINK to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.

Continue Reading

Weekly Recap: 13 Health Press Releases You Might Have Missed Image

PR Newswire Weekly Health Press Release Roundup, Sept. 23-27, 2024. Photo provided by ASICS.

  • FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
    The
    U.S. Food and Drug Administration (FDA) approved FluMist for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. The vaccine is sprayed into the nose and has been used safely and effectively for many years.
  • Nearly Two-Thirds of Americans Fear Medicare Will Not Be There When They Need It
    "Concerns about the future of Medicare are adding another layer of uncertainty for Americans as they consider how they'll manage health care costs in retirement," said
    Kristi Martin Rodriguez, senior vice president of the Nationwide Retirement Institute. "With high living costs already squeezing household budgets, many are worried about having enough saved to cover their long-term health care."
  • Cardinal Health to Acquire Integrated Oncology Network, a Physician-Led Independent Community Oncology Network
    The transaction demonstrates Cardinal Health's continued investment in specialty and oncology, adding more than 100 providers at more than 50 community-based sites delivering broad-reaching oncology and urology care across 10 states.
  • ADHD Redefined: ADDitude Honors ADHD Empowerment Month with Groundbreaking Campaign
    Throughout October,
    ADDitude will highlight a new definition of ADHD each day, sharing inspiring stories of readers who have contributed their personal experiences. The campaign will also feature exclusive profiles of prominent figures in the ADHD community, including novelist Rebecca Makkai, stand-up comedian Rachel Feinstein, and illustrator Hayley Wall, who explain how ADHD shaped their creativity and careers.
  • Halle Berry's Respin and Menopause Pioneer Joylux Announce Strategic Partnership to Advance Intimate Health & Wellness
    Halle Berry is a passionate advocate for women's health, especially concerning menopause. The collaboration marks a significant milestone for Respin and Joylux as they work together to destigmatize the taboo of intimate health with science-backed solutions that empower women to take control of their health.
  • Hear Powerful Stories of Individuals Living with Familial Hypercholesterolemia in ABC's "Family Heartbeats Unmasked"
    The new campaign from the Association of Black Cardiologists (ABC) is dedicated to raising awareness about Familial Hypercholesterolemia (FH), a genetic condition that significantly increases the risk of early heart disease and is often underdiagnosed, especially in Black Americans and other minority populations.
  • Flex Confirms Period Discs and Cups Are Free from Harmful Metals and PFAS Amid Concerns Over Toxic Chemicals in Tampons
    Flex announced that independent third-party lab testing confirmed all Flex menstrual discs and cups are free from harmful PFAS (forever chemicals), lead, arsenic, cadmium, and mercury. This follows the FDA's recent decision to investigate toxic metals found in tampons, fueling discussions about the need for more research and innovation in menstrual health.
  • Brian Cox Warns the World About Workplace Mental Health Threat in PSA for ASICS
    In the PSA,
    Brian Cox
    plays the role of the world's scariest boss to highlight the silent threat to our mental health-the desk we work at every day. The PSA calls on office workers to put their mental health first by taking a Desk Break, a short movement break, during the working day.
  • WebMD Announces 2024 Health Heroes: Visionaries Leveraging AI in Medicine
    "Artificial Intelligence is reshaping healthcare in profound ways, saving lives and improving patient outcomes," said Dr. John
    Whyte, Chief Medical Officer of WebMD. "This year's Health Heroes are leading the way in AI innovation, and we are honored to recognize their achievements."
  • Bosley and Lumenis Partner to Introduce Breakthrough Hair Loss Solution, FoLixTM, to the U.S.
    The partnership initiates a new era in hair loss treatment by introducing the first FDA-cleared fractional laser solution for hair loss to U.S. customers for the first time, potentially transforming the lives of millions of people affected by hair loss in the U.S.
  • NYU Langone Health Forms New Partnership to Minimize Deaths from Extreme Heat Amid Rising Global Temperatures
    Project HEATWAVE (Heat Emergency Avoidance Technologies Working to Adapt to Vulnerabilities Equitably), according to its founders, will be the first-ever initiative to combine advanced climate modeling, public health analysis and policy, and medical and technology innovation to study and help reduce heat-related mortality due to climate change.
  • October is
    Raynaud's Awareness Month

    Raynaud's phenomenon is a disorder that affects blood vessels, primarily in the fingers and toes, causing them to constrict in response to cold temperatures or stress. This loss of blood flow can result in episodes of numbness, tingling, and color changes in the affected areas.
  • Seelos Therapeutics Announces the Signing of a Material Transfer Agreement with U.S. Army Medical Materiel Development Activity (USAMMDA) to Evaluate SLS-002 for Treatment of PTSD

    "Approximately 13 million people in the U.S. live with PTSD and there have been no new drugs approved in the last two decades for people suffering the effects of PTSD," said Raj Mehra, Ph.D., Chief Executive Officer of Seelos. "I believe that the inclusion of SLS-002 in this study is due to the robust amount of anecdotal evidence that ketamine has the potential to be an effective therapeutic for the symptoms of PTSD and other related conditions."

    For more news like this, check out all of
    the latest health-related releases from PR Newswire .

    Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.

    Helping Journalists Stay Up to Date on Industry News

    These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists .

    Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:

    • Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.
    • Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story.
    • Subject Matter Experts: Journalists will have access to ProfNet , a database of industry experts to connect with as sources or for quotes in their articles.
    • Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines , features regular media news roundups, writing tips, upcoming events, and more.

    About PR Newswire

    PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

    For questions, contact the team at [email protected] .

    SOURCE PR Newswire

    WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
    Newsrooms &
    Influencers 9k+
    Digital Media
    Outlets 270k+
    Journalists
    Opted In GET STARTED

    MENAFN27092024003732001241ID1108722446


  • PR Newswire

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.